Novaptech
PrivateLast Round
Early Funding
Feb 1, 2019
Total Funding Raised
$530,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Novaptech operates in Healthcare & Life Sciences and is based in Gradignan. Its latest recorded funding round was an Early Funding round in February 2019.
Novaptech is a biotechnology company that provides custom aptamer development services for diagnostics and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novaptech Comparables
Compare Novaptech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Base Pair Biotechnologies | 92% | |
| Aptagen, LLC | 88% | |
| NeoVentures Biotechnology Inc. | 86% |
For institutional investors. Book with your work email.
Novaptech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 1, 2019 | ||||
| Seed | Jan 24, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novaptech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Unitec | Seed |
| Aquiti Gestion | Early Funding, Seed |
| Région Nouvelle-Aquitaine | Grant, Seed |
| Aquitaine Science Transfert | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 1722% MoM, from 37 to 674.
- Jan 27, 2026
Monthly visitors grew 126% MoM, reaching 1K.
For institutional investors. Book with your work email.
Novaptech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novaptech's valuation, stock price, and market status.
Is Novaptech a public or private company?
Novaptech is a private company.
What is the current stock price of Novaptech?
Novaptech is a private company, so its shares have no public market price. Caplight tracks Novaptech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novaptech worth (valuation)?
Valuation information for Novaptech is not publicly available.
Can I buy Novaptech stock?
Novaptech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novaptech's last funding round?
Novaptech's most recent funding round was Early Funding on February 1, 2019.
Who are the main investors in Novaptech?
Key investors in Novaptech include Unitec, Aquiti Gestion, Région Nouvelle-Aquitaine, Aquitaine Science Transfert, Bpifrance.
Will Novaptech IPO soon?
No public IPO plans have been announced for Novaptech.
How can I track Novaptech secondary market activity?
Caplight tracks bids, offers, and trades in Novaptech's shares on secondary markets.